首页> 外文期刊>European journal of human genetics: EJHG >Intragenic and large NIPBL rearrangements revealed by MLPA in Cornelia de Lange patients
【24h】

Intragenic and large NIPBL rearrangements revealed by MLPA in Cornelia de Lange patients

机译:MLPA在Cornelia de Lange患者中揭示了基因内和大的NIPBL重排

获取原文
获取原文并翻译 | 示例
       

摘要

Cornelia de Lange syndrome (CdLS) is a rare multisystemic congenital anomaly disorder that is characterised by intellectual disability and growth retardation, congenital heart defects, intestinal anomalies, facial dysmorphism (including synophyris and high arched eyebrows) and limb reduction defects. Mutations in three cohesin-associated genes encoding a key regulator (NIPBL, chr 5p13.2) and one structural component of the cohesin ring (SMC1A, chr Xp11) occur in about 65% of CdLS patients. NIPBL is the major causative gene, and accounts for 40-60% of CdLS patients as shown by a number of mutational screening studies that indicate a wide mutational repertoire of mainly small deletions and point mutations. Only a few data are available concerning the occurrence of large NIPBL rearrangements or intragenic deletions or duplications involving whole exons. We used multiplex ligation-dependent probe amplification (MLPA) to study 132 CdLS patients negative to the standard mutation NIPBL test out of a cohort of 200 CdLS patients. A total of 7 out of 132 patients were found to carry NIPBL alterations, including two large gene deletions extending beyond the gene, four intragenic multi-or single-exon deletions and one single-exon duplication. These findings show that MLPA leads to a 5.3% increase in the detection of mutations when used in addition to the standard NIPBL scan, and contributes per se to the molecular diagnosis of 3.5% (7/200) of clinically diagnosed CdLS patients. It is recommended that MLPA be included in the CdLS diagnostic flow chart.
机译:Cornelia de Lange综合征(CdLS)是一种罕见的多系统先天性异常疾病,其特征是智力残疾和生长迟缓,先天性心脏缺陷,肠道异常,面部畸形(包括突触和高弓形眉毛)和四肢减少缺陷。大约65%的CdLS患者发生了三个与黏蛋白相关的编码关键调节因子(NIPBL,chr 5p13.2)和黏蛋白环的结构成分(SMC1A,chr Xp11)的突变。 NIPBL是主要的致病基因,许多突变筛选研究表明,NIPBL占CdLS患者的40-60%,这些研究表明,广泛的突变谱主要是小缺失和点突变。关于大的NIPBL重排或涉及整个外显子的基因内缺失或重复的发生,只有少数数据可用。我们使用多重连接依赖探针扩增(MLPA)研究了200名CdLS患者队列中对标准突变NIPBL测试呈阴性的132名CdLS患者。在132名患者中,共发现7名患者携带NIPBL改变,包括2个超出基因的大基因缺失,4个基因内多或单外显子缺失和1个单外显子重复。这些发现表明,除了使用标准的NIPBL扫描外,使用MLPA还能使突变检测率提高5.3%,并本身为3.5%(7/200)的临床诊断CdLS患者进行分子诊断。建议将MLPA包含在CdLS诊断流程图中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号